Target intelligence / Profile preview

Proteoglycan 3, pro-eosinophil major basic protein 2 pseudogene (SLED1)

Target
SLED1
Molecular classification
Other (Pseudogene)
01

Overview

SLED1 (Proteoglycan 3, pro-eosinophil major basic protein 2 pseudogene) is classified as a pseudogene located on human chromosome 4q35.1 and is not known to encode a functional protein product[1][5][6]. It is sometimes referred to as RTFV9368 or "proteoglycan 3 pseudogene." Because it is a pseudogene—designated as such due to the presence of mutations or features preventing functional protein expression—it is not considered a therapeutic target, receptor, enzyme, transporter, or any functional molecule with biological, pathological, or pharmacological significance[1][5][6]. There are no known biological functions, disease associations, mechanisms, biomarkers, safety concerns, or drug interactions relevant to this locus. The entry might appear as a candidate in gene lists due to nomenclature overlap with functional proteoglycan family members, but in this case, there is no evidence of physiological or therapeutic relevance.

Other names
RTFV9368proteoglycan 3 pseudogeneSLED1

Beyond the preview

Go deeper on Proteoglycan 3, pro-eosinophil major basic protein 2 pseudogene (SLED1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteoglycan 3, pro-eosinophil major basic protein 2 pseudogene (SLED1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call